Cargando…
Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report
Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive skin fibrosis. It has 2 main clinical subtypes—diffuse cutaneous scleroderma and limited cutaneous scleroderma. Non-cirrhotic portal hypertension (NCPH) is defined as presence of elevated portal vein pressures without cir...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161292/ https://www.ncbi.nlm.nih.gov/pubmed/37132021 http://dx.doi.org/10.1177/23247096231171251 |
_version_ | 1785037462365536256 |
---|---|
author | Hitawala, Asif Ali Redmond, Christopher Cowen, Edward W. Kleiner, David E. Hasni, Sarfaraz Heller, Theo |
author_facet | Hitawala, Asif Ali Redmond, Christopher Cowen, Edward W. Kleiner, David E. Hasni, Sarfaraz Heller, Theo |
author_sort | Hitawala, Asif Ali |
collection | PubMed |
description | Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive skin fibrosis. It has 2 main clinical subtypes—diffuse cutaneous scleroderma and limited cutaneous scleroderma. Non-cirrhotic portal hypertension (NCPH) is defined as presence of elevated portal vein pressures without cirrhosis. It is often a manifestation of an underlying systemic disease. On histopathology, NCPH may be found to be secondary to multiple abnormalities such as nodular regenerative hyperplasia (NRH) and obliterative portal venopathy. There have been reports of NCPH in patients with both subtypes of SSc secondary to NRH. However, simultaneous presence of obliterative portal venopathy has not been reported. We present a case of NCPH due to NRH and obliterative portal venopathy as a presenting sign of limited cutaneous scleroderma. The patient was initially found to have pancytopenia and splenomegaly and was erroneously labeled as cirrhosis. She underwent workup to rule out leukemia, which was negative. She was referred to our clinic and diagnosed with NCPH. Due to pancytopenia, she could not be started on immunosuppressive therapy for her SSc. Our case describes the presence of these unique pathological findings in the liver and highlights the importance of an aggressive search for an underlying condition in all patients diagnosed with NCPH. |
format | Online Article Text |
id | pubmed-10161292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-101612922023-05-06 Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report Hitawala, Asif Ali Redmond, Christopher Cowen, Edward W. Kleiner, David E. Hasni, Sarfaraz Heller, Theo J Investig Med High Impact Case Rep Case Report Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive skin fibrosis. It has 2 main clinical subtypes—diffuse cutaneous scleroderma and limited cutaneous scleroderma. Non-cirrhotic portal hypertension (NCPH) is defined as presence of elevated portal vein pressures without cirrhosis. It is often a manifestation of an underlying systemic disease. On histopathology, NCPH may be found to be secondary to multiple abnormalities such as nodular regenerative hyperplasia (NRH) and obliterative portal venopathy. There have been reports of NCPH in patients with both subtypes of SSc secondary to NRH. However, simultaneous presence of obliterative portal venopathy has not been reported. We present a case of NCPH due to NRH and obliterative portal venopathy as a presenting sign of limited cutaneous scleroderma. The patient was initially found to have pancytopenia and splenomegaly and was erroneously labeled as cirrhosis. She underwent workup to rule out leukemia, which was negative. She was referred to our clinic and diagnosed with NCPH. Due to pancytopenia, she could not be started on immunosuppressive therapy for her SSc. Our case describes the presence of these unique pathological findings in the liver and highlights the importance of an aggressive search for an underlying condition in all patients diagnosed with NCPH. SAGE Publications 2023-05-02 /pmc/articles/PMC10161292/ /pubmed/37132021 http://dx.doi.org/10.1177/23247096231171251 Text en © 2023 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Hitawala, Asif Ali Redmond, Christopher Cowen, Edward W. Kleiner, David E. Hasni, Sarfaraz Heller, Theo Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report |
title | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report |
title_full | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report |
title_fullStr | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report |
title_full_unstemmed | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report |
title_short | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report |
title_sort | non-cirrhotic portal hypertension as the initial presentation of limited cutaneous scleroderma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161292/ https://www.ncbi.nlm.nih.gov/pubmed/37132021 http://dx.doi.org/10.1177/23247096231171251 |
work_keys_str_mv | AT hitawalaasifali noncirrhoticportalhypertensionastheinitialpresentationoflimitedcutaneoussclerodermaacasereport AT redmondchristopher noncirrhoticportalhypertensionastheinitialpresentationoflimitedcutaneoussclerodermaacasereport AT cowenedwardw noncirrhoticportalhypertensionastheinitialpresentationoflimitedcutaneoussclerodermaacasereport AT kleinerdavide noncirrhoticportalhypertensionastheinitialpresentationoflimitedcutaneoussclerodermaacasereport AT hasnisarfaraz noncirrhoticportalhypertensionastheinitialpresentationoflimitedcutaneoussclerodermaacasereport AT hellertheo noncirrhoticportalhypertensionastheinitialpresentationoflimitedcutaneoussclerodermaacasereport |